Eosinophilic Esophagitis is a chronic inflammatory disease characterized by eosinophil infiltration and activation in the esophagus. It is considered as a complex disease resulting from an interaction between genetic and environmental factors leading to immune responses in the esophagus. Some of the primary symptoms associated with the disease include difficulty swallowing, abdominal pain, vomiting, and diarrhea. The conventional treatment options include topical corticosteroids, dietary modifications, and specially formulated food to manage the symptoms. The rising incidences of allergic disorders including food allergy, aeroallergens, and gastrointestinal disorders are expected to drive the growth of eosinophilic esophagitis market during the forecast period.
The global Eosinophilic Esophagitis Market is estimated to be valued at US$ 245.92 Mn in 2023 and is expected to exhibit a CAGR of 61% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The key trend fueling the growth of the eosinophilic esophagitis market is increasing adoption of novel treatment options. Several pharmaceutical companies are investing in research and development activities to develop innovative and advanced therapies to treat eosinophilic esophagitis more effectively. New therapies in late stage of clinical trials including biologics and small molecules targeting specific molecules involved in eosinophil recruitment and activation in esophagus. They are expected show more resistance to diseases and help manage the symptoms effectively. This is anticipated to provide lucrative opportunities for the players in the market during the forecast period.
Segment Analysis
The global Eosinophilic Esophagitis market is dominated by the food & drug allergens induced Eosinophilic Esophagitis sub-segment. Over 80% of the cases are caused by food allergens such as milk, eggs, soy, wheat, nuts, and seafood. These proteins provoke an immune response leading to inflammation and damage of the esophagus.
Key Takeaways
The global Eosinophilic Esophagitis Market Demand is expected to witness high growth over the forecast period of 2023-2030. The global Eosinophilic Esophagitis Market is estimated to be valued at US$ 245.92 Mn in 2023 and is expected to exhibit a CAGR of 61% over the forecast period 2023 to 2030.
Regional analysis
The Asia Pacific region is poised to witness the fastest CAGR during the forecast period. This is attributed to growing healthcare expenditure, increasing awareness regarding the disease, and improving diagnosis rate in major countries of the region. Countries like India and China are expected to drive the regional market.
Key players
Key players operating in the Eosinophilic Esophagitis market are AutoX, Inc., Baidu, BMW AG, Daimler AG, EasyMile, Ford Motor Company, GM Cruise LLC, Hyundai, Tesla, Inc. AutoX, Inc. focuses on developing autonomous vehicles that increase road safety.
Get More Insights On This Topic: https://www.ukwebwire.com/the-eosinophilic-esophagitis-market-driven-by-increasing-prevalence/
